Search PubMed⌕ Search

PubMed · 12843772

Quantifying and reporting uncertainty from systematic errors.

Abstract

Optimal use of epidemiologic findings in decision making requires more information than standard analyses provide. It requires calculating and reporting the total uncertainty in the results, which in turn requires methods for quantifying the uncertainty introduced by systematic error. Quantified uncertainty can improve policy and clinical decisions, better direct further research, and aid public understanding, and thus enhance the contributions of epidemiology. The error quantification approach proposed here is based on estimating a probability distribution for a bias-corrected effect measure based on externally-derived distributions of bias levels. Using Monte Carlo simulation, corrections for multiple biases are combined by identifying the steps through which true causal effects become data, and (in reverse order) correcting for the errors introduced by each step. The bias-correction calculations are the same as those used in sensitivity analysis, but the resulting distribution of possible true values is more than a sensitivity analysis; it is a more complete reporting of the actual study results. The approach is illustrated with an application to a recent study that resulted in the drug, phenylpropanolamine, being removed from the market.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Carl V Phillips. 2003. Quantifying and reporting uncertainty from systematic errors.. https://doi.org/10.1097/01.ede.0000072106.65262.ae

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Determination of the active metabolite of sibutramine by liquid chromatography-electrospray ionization tandem mass spectrometry.

A sensitive and specific method for the determination of the active primary amine metabolite of sibutramine, N-di-desmethylsibutramine (BTS 54,505), in human plasma was developed, based on high-performance liquid chromatography (HPLC)-electrospray ionization tandem mass spectrometry (MS-MS). The samples were extracted from plasma with methyl tert.-butyl ether, followed by separation and evaporation after addition of the internal standard, propranolol, and basification with sodium hydroxide. The residue was reconstituted in mobile phase and injected into the HPLC-MS-MS system. Chromatography was performed on an ODS MS column with a mobile phase consisting of acetonitrile (containing 0.1% trifluoroacetic acid, v/v)-0.1% trifluoroacetic acid (55:45, v/v) at a flow-rate of 0.3 ml/min. Multiple reaction monitoring using precursor-->product ion combinations at m/z 252.00-->125.00 and 260.00-->115.70 was applied to determine BTS 54,505 and propranolol, respectively. Linearity was confirmed in the concentration range 0.328-32.8 ng/ml in human plasma and the imprecision of this assay was less than 19.90% over the entire concentration range. The method is sufficiently sensitive and repeatable to be used in pharmacokinetic studies.

Appetite Depressants↗